Significant Ownership of QVT Financial LP

Signature - Title
/s/ Meg Eisner - Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by QVT Financial LP.

Notify me when QVT Financial LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of QVT Financial LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLT Allot Ltd. Ordinary Shares, par value ILS 0.10 per share 10% $47,739,592 +$14,208,464 5,062,523 +42% QVT Financial LP 18 Nov 2025
WHWK Aadi Bioscience, Inc. Common stock, $0.0001 par value per share 9.4% $3,817,608 2,313,702 QVT Financial LP 31 Dec 2024
TRML Tourmaline Bio, Inc. Common Stock, $0.0001 par value per share 8.4% $49,686,298 +$15,710,409 2,154,653 +46% QVT Financial LP 30 Jun 2025
ROIV Roivant Sciences Ltd. Common shares, par value $0.0000000341740141 per share 4.3% $351,404,355 -$435,489,242 29,381,635 -55% QVT Financial LP 30 Jun 2025

Schedules 13D/G Reported by QVT Financial LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.